Prognostic Significance of Antithrombin Activity in Patients with Crimean-Congo Hemorrhagic Fever | Zendy

Zülal Özkurt | Zendy; Kemalettin Özden | Zendy; İlhami Kıkı | Zendy; Mustafa Usanmaz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prognostic Significance of Antithrombin Activity in Patients with Crimean-Congo Hemorrhagic Fever

Author(s) -

Zülal Özkurt,

Kemalettin Özden,

İlhami Kıkı,

Mustafa Usanmaz

Publication year - 2011

Publication title -

eurasian journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.337

H-Index - 13

eISSN - 1308-8742

pISSN - 1308-8734

DOI - 10.5152/eajm.2011.19

Subject(s) - medicine , crimean–congo hemorrhagic fever , antithrombin , gastroenterology , prothrombin time , platelet , white blood cell , coagulation , disseminated intravascular coagulation , complication , immunology , disease , heparin

Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne viral hemorrhagic fever. Disseminated intravascular coagulation (DIC) is an important complication of this disease, especially in severe and fatal cases. Antithrombin (AT) acts as an anticoagulant by inactivating thrombin, Factor IX, Factor X and Factor XI. We conducted this study to investigate the AT levels and their prognostic value in CCHF.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research